ZA982403B - Detection of endometrial cancer - Google Patents

Detection of endometrial cancer

Info

Publication number
ZA982403B
ZA982403B ZA982403A ZA982403A ZA982403B ZA 982403 B ZA982403 B ZA 982403B ZA 982403 A ZA982403 A ZA 982403A ZA 982403 A ZA982403 A ZA 982403A ZA 982403 B ZA982403 B ZA 982403B
Authority
ZA
South Africa
Prior art keywords
endometrial cancer
detection
matrix metalloproteinase
assaying
qualitative
Prior art date
Application number
ZA982403A
Other languages
English (en)
Inventor
Alexander Lopata
Lois A Salamonsen
Michael A Quinn
Original Assignee
Univ Melbourne
Prince Henrys Inst Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne, Prince Henrys Inst Med Res filed Critical Univ Melbourne
Publication of ZA982403B publication Critical patent/ZA982403B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA982403A 1997-03-20 1998-03-20 Detection of endometrial cancer ZA982403B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO5736A AUPO573697A0 (en) 1997-03-20 1997-03-20 Diagnosis of endometrial cancer

Publications (1)

Publication Number Publication Date
ZA982403B true ZA982403B (en) 1998-10-21

Family

ID=3800039

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982403A ZA982403B (en) 1997-03-20 1998-03-20 Detection of endometrial cancer

Country Status (14)

Country Link
US (1) US6607894B1 (fr)
EP (1) EP0979304B1 (fr)
JP (2) JP4183757B2 (fr)
KR (1) KR20010006344A (fr)
CN (1) CN1257550A (fr)
AT (1) ATE331039T1 (fr)
AU (1) AUPO573697A0 (fr)
CA (1) CA2284099C (fr)
DE (1) DE69835010T2 (fr)
ES (1) ES2268767T3 (fr)
MY (1) MY119567A (fr)
NZ (1) NZ337868A (fr)
WO (1) WO1998042865A1 (fr)
ZA (1) ZA982403B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322023A1 (fr) * 1998-03-05 1999-09-10 John D. Burczak Nouveau procede de detection et de surveillance d'un cancer endometrial ou uterin
AUPQ219799A0 (en) 1999-08-13 1999-09-02 R. Lurie Pty Ltd Apparatus for obtaining potological samples
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
DE10217677A1 (de) 2002-04-19 2003-11-06 Bayer Ag Verwendung von Aufhellern zur Herstellung von Streichmassen
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
EP1782068B1 (fr) * 2004-07-23 2010-04-07 Centre de Recherche Public de la Santé Surveillance d'une insuffisance cardiaque
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
MX2007009566A (es) * 2005-02-09 2009-02-16 Genentech Inc Inhibicion de la difusion de la her2 con antagonistas de la metaloproteasa de matriz.
US7504225B2 (en) * 2005-05-12 2009-03-17 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
ES2567079T3 (es) 2007-11-02 2016-04-19 Momenta Pharmaceuticals, Inc. Composiciones de polisacáridos que no son anticoagulantes
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
WO2010121196A1 (fr) * 2009-04-16 2010-10-21 Momenta Pharmaceuticals, Inc. Procédés d'évaluation de l'activité d'une composition de polysaccharide
CN105132529A (zh) * 2009-07-24 2015-12-09 吉第克生物技术有限公司 子宫内膜癌的标记物
US9387256B2 (en) 2010-04-16 2016-07-12 Momenta Pharmaceuticals, Inc. Tissue targeting
US10017585B2 (en) 2010-06-17 2018-07-10 Momenta Pharmaceuticals, Inc. Methods and compositions for promoting hair growth
AU2012261953A1 (en) * 2011-06-03 2013-12-12 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
CA2849817A1 (fr) * 2011-09-22 2013-03-28 Memorial Sloan-Kettering Cancer Center Detection du cancer de l'ovaire
PT2809801T (pt) * 2012-01-31 2018-11-20 Paul Speiser Sistema auxiliar electro-hidráulico.
WO2014193818A1 (fr) 2013-05-28 2014-12-04 Momenta Pharmaceuticals, Inc. Compositions pharmaceutiques
WO2016000028A1 (fr) * 2014-07-02 2016-01-07 Bionomics Limited Biomarqueurs prédictifs
US20180094301A1 (en) * 2015-02-06 2018-04-05 Quest Diagnostics Investments Llc Compositions and methods for determining endometrial cancer prognosis
WO2017190896A1 (fr) * 2016-05-04 2017-11-09 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Utilisation de la mmp9 comme marqueur du cancer de l'endomètre
IN202021002695A (fr) 2020-01-21 2021-07-23
CN112961921B (zh) * 2021-03-26 2022-07-01 中国医学科学院北京协和医院 一种用于判断早期子宫内膜癌预后的制剂及复发风险模型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
US5324634A (en) 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
WO1994005807A1 (fr) * 1992-08-28 1994-03-17 Dickson Robert B Metalloproteinase decomposant les matrices
AU6396494A (en) * 1992-11-16 1994-06-08 Cancer Research Fund Of Contra Costa Peptides and anti-sense peptides with broad neoplastic specificity

Also Published As

Publication number Publication date
KR20010006344A (ko) 2001-01-26
DE69835010T2 (de) 2007-06-06
CA2284099C (fr) 2010-04-27
CN1257550A (zh) 2000-06-21
NZ337868A (en) 2002-05-31
JP2007202556A (ja) 2007-08-16
EP0979304A1 (fr) 2000-02-16
ES2268767T3 (es) 2007-03-16
DE69835010D1 (de) 2006-08-03
US6607894B1 (en) 2003-08-19
JP2002501613A (ja) 2002-01-15
EP0979304B1 (fr) 2006-06-21
ATE331039T1 (de) 2006-07-15
WO1998042865A1 (fr) 1998-10-01
AUPO573697A0 (en) 1997-04-10
EP0979304A4 (fr) 2003-06-11
JP4183757B2 (ja) 2008-11-19
CA2284099A1 (fr) 1998-10-01
MY119567A (en) 2005-06-30

Similar Documents

Publication Publication Date Title
ZA982403B (en) Detection of endometrial cancer
HK1040533A1 (zh) 監察蛋白脢體抑制劑藥物活動的方法
AU4157696A (en) Quantitative method for early detection of mutant alleles and diagnostic kits for carrying out the method
IL143892A0 (en) Kidney disease detection and treatment
ES2165402T3 (es) Procedimiento para la deteccion sensible de acidos nucleicos.
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
EP0932699A4 (fr) Procedes et trousses utilises pour produire et analyser des echantillons de fluide mammaire afin de determiner des maladies du sein, dont le cancer
EP0132313A3 (en) Reagents, test kits and methods for the detection of cannabinoids
EP0700448A4 (fr) Amelioration d'un procede et d'un systeme d'analyse permettant des titrages du fibrinogene precis, rapides et simples
WO2003048300A3 (fr) Procedes d'identification de molecules cibles cellulaires
IL129390A0 (en) Method and kit for detecting genetic predisposition to slight-threatening diabetic retinopathy
MX9300495A (es) Metodo rapido y cuantitativo, altamente sensible para detectar y cuantificar el arn mensajero en una muestra.
EP0229674A3 (en) Test to determine predisposition or susceptibility to dna associated diseases
ES2175095T3 (es) Marcadores de adn respecto al tamaño de una camada de cerdos.
CA2269664A1 (fr) Methode diagnostique pour determiner la predisposition d'un sujet a developper un carcinome mammaire
DE3264721D1 (en) Reagent for assaying hydrogen peroxide and method of quantitative assay for hydrogen peroxide
PL335543A1 (en) Prenatal diagnosing methods
GB9604305D0 (en) Diagnostic method and apparatus
EP0657547A4 (fr) Methode de titrage de l'activite de l'antithrombine iii et kit de reactifs con u a cet effet.
EP1141703A4 (fr) Methodes de determination de risque augmente pour une femme portant un foetus atteint du syndrome de down
WO1999054707A3 (fr) Epreuve foetale de prevision de poids faible a la naissance
EP0158224A3 (en) Analysis method and means for detecting esterolytic and/or proteolytic enzymes
EP0157361A3 (en) Analysis method and means for detecting esterolytic and or proteolytic enzymes
Africa An act (No. 92 of 1996) to determine the circumstances in which and conditions under which the pregnancy of a woman may be terminated; and to provide for matters connected therewith. Date of assent: 12 Nov 1996.(The Choice on Termination of Pregnancy Act, 1996).(Government Gazette, 22 Nov 1996, Vol 377, No. 17602, pp. 1-10)
UA33566A (uk) Спосіб кількісного визначення ципрофлоксацину